MSL Global

Why is Madhusudan Securities Ltd falling/rising?

As of 12-Aug, MSL Global Ltd's stock price is rising to Rs. 15.78, with a 1.81% increase and notable investor participation. However, it remains below key moving averages and has declined 38.93% year-to-date, indicating ongoing challenges.

As of 12-Aug, MSL Global Ltd's stock price is rising, currently at Rs. 15.78, reflecting an increase of Rs. 0.28 or 1.81%. This upward movement is notable as the stock has outperformed its sector by 1.98% today. Additionally, there has been a significant rise in investor participation, with a delivery volume of 1.41k on 11 August, which is up by 62.27% compared to the 5-day average. <BR><BR>However, it is important to note that despite today's positive performance, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Furthermore, the stock has experienced a significant decline year-to-date, down 38.93%, and has recently hit a new 52-week low of Rs. 15. <BR><BR>In summary, while MSL Global Ltd is experiencing a rise in its stock price today, driven by increased investor participation and sector outperformance, the overall trend indicates challenges, including a substantial year-to-date decline and trading below key moving averages.

Which are the latest news on MSL Global?

When is the next results date for Madhusudan Securities Ltd?

The next results date for Madhusudan Securities Ltd is 14 August 2026.

The next results date for Madhusudan Securities Ltd is scheduled for 14 August 2026.

How big is Madhusudan Sec.?

As of 10th June, Madhusudan Securities Ltd has a market capitalization of 39.00 Cr, with recent net sales of 7.28 Cr and a net profit of 2.81 Cr. The balance sheet for March 2025 shows shareholder's funds of 81.55 Cr and total assets of 84.80 Cr.

As of 10th June, Madhusudan Securities Ltd has a market capitalization of 39.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 7.28 Cr and a Net Profit of 2.81 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 81.55 Cr and Total Assets of 84.80 Cr.

Who are in the management team of Madhusudan Sec.?

The management team of Madhusudan Securities includes Salim Pyarali Govani as Chairman & Managing Director, Harsh Pradip Javeri and Sasuan Bukhari as Non-Executive & Independent Directors, and Kratika Sharma as Company Secretary & Compliance Officer.

The management team of Madhusudan Securities includes the following individuals:<BR><BR>1. **Salim Pyarali Govani** - Chairman & Managing Director<BR>2. **Harsh Pradip Javeri** - Non-Executive & Independent Director<BR>3. **Sasuan Bukhari** - Non-Executive & Independent Director<BR>4. **Kratika Sharma** - Company Secretary & Compliance Officer<BR><BR>If you need more details about their roles or the company, feel free to ask!

Who are the peers of the Madhusudan Sec.?

Madhusudan Sec.'s peers include Pan India Corpor, Prism Medico, Ajcon Global, Kiduja India, Anupam Finserv, BSEL ALGO, HB Stockholdings, Key Corp, and Biogen Pharma. While Madhusudan Sec. shows excellent growth and capital structure, its 1-year return of -22.00% is better than Biogen Pharma's but worse than Prism Medico's 87.28%.

Peers: The peers of Madhusudan Sec. are Pan India Corpor, Prism Medico, Ajcon Global, Kiduja India, Anupam Finserv, BSEL ALGO, HB Stockholdings, Key Corp, and Biogen Pharma.<BR><BR>Quality Snapshot: Below Average management risk is observed at Madhusudan Sec., Prism Medico, Ajcon Global, Anupam Finserv, BSEL ALGO, HB Stockholdings, Key Corp, and Biogen Pharma, while Average management risk is found at Key Corp. Excellent growth is noted at Madhusudan Sec., while Below Average growth is seen at Prism Medico, Ajcon Global, Anupam Finserv, and the rest. Excellent capital structure is present at Madhusudan Sec., Ajcon Global, Anupam Finserv, BSEL ALGO, HB Stockholdings, and Key Corp, while Below Average capital structure is observed at Prism Medico and the rest.<BR><BR>Return Snapshot: Prism Medico has the highest 1-year return at 87.28%, while Biogen Pharma has the lowest at -64.95%. Madhusudan Sec.'s 1-year return of -22.00% is better than Biogen Pharma's but worse than Prism Medico's. Additionally, several peers, including Ajcon Global, Kiduja India, Anupam Finserv, BSEL ALGO, HB Stockholdings, Key Corp, and Biogen Pharma, have negative six-month returns.

What does Madhusudan Sec. do?

Madhusudan Securities Ltd is a micro-cap NBFC primarily focused on the garments sector, having shifted its business model in 2011. As of March 2026, it reported net sales of 2 Cr and a market cap of INR 39 Cr.

Overview: <BR>Madhusudan Securities Ltd is a micro-cap company operating in the Non-Banking Financial Company (NBFC) sector, primarily involved in the business of garments.<BR><BR>History: <BR>Madhusudan Securities Ltd was incorporated in 1982 and was previously known as Madhusudan Investments Ltd before changing its name on September 29, 1995. The company shifted its main business focus in 2011 to deal with readymade or made-to-measure garments. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 2 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 39 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 5.97% <BR>Price to Book: 0.46 <BR><BR>Contact Details: <BR>Address: 37 National Storage Building, Plot No 424-B SB Road Mahim(W) Mumbai Maharashtra : 400016 <BR>Email: mslsecurities@yahoo.com <BR>Website: http://www.mslsecurities.com

Is Madhusudan Sec. overvalued or undervalued?

As of December 4, 2025, Madhusudan Securities is considered very expensive and overvalued due to negative financial ratios and poor performance compared to peers, with a recent stock decline of 12.77% over the past year.

As of 4 December 2025, the valuation grade for Madhusudan Securities has moved from risky to very expensive. The company is currently considered overvalued based on its financial ratios and peer comparisons. Key ratios include a PE Ratio of -73.65, an EV to EBITDA of -32.91, and a Price to Book Value of 0.41, which indicate significant financial distress.<BR><BR>In comparison to its peers, Madhusudan Securities stands out unfavorably; for instance, Bajaj Finance has a PE Ratio of 34.9 and an EV to EBITDA of 19.63, while Life Insurance boasts a PE of 10.85 and an EV to EBITDA of 8.92, both of which suggest more favorable valuations. Despite a recent positive stock return of 4.32% over the past week, the overall trend shows a decline of 12.77% over the past year, contrasting sharply with the Sensex's 5.32% gain in the same period. This reinforces the notion that Madhusudan Securities is overvalued in its current state.

How has been the historical performance of Madhusudan Sec.?

Madhusudan Sec. experienced a significant decline in financial performance from March 2024 to March 2025, with net sales dropping to 0.07 Cr from 0.45 Cr, resulting in a consolidated net loss of -0.83 Cr compared to a profit of 0.15 Cr the previous year. Key metrics such as operating profit and shareholder's funds also decreased substantially, indicating a challenging financial year.

Answer:<BR>The historical performance of Madhusudan Sec. shows a significant decline in financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Madhusudan Sec. reported net sales of 0.07 Cr, a decrease from 0.45 Cr in the previous year. Total operating income also fell to 0.07 Cr from 0.45 Cr, while total expenditure increased to 0.59 Cr from 0.30 Cr. This led to an operating profit (PBDIT) of -0.52 Cr, down from a positive 0.15 Cr in March 2024. Consequently, profit before tax dropped to -0.52 Cr, and profit after tax decreased to -0.53 Cr from a profit of 0.15 Cr the prior year. The consolidated net profit for March 2025 was -0.83 Cr, compared to a profit of 0.15 Cr in March 2024. The earnings per share (EPS) reflected this downturn, falling to -0.75 from 0.17. On the balance sheet, shareholder's funds decreased to 81.55 Cr from 156.54 Cr, and total assets dropped to 84.80 Cr from 167.99 Cr. Cash flow from operating activities turned negative at -8.00 Cr, contrasting with a positive 9.00 Cr in the previous year, although cash flow from financing activities showed an inflow of 14.00 Cr. Overall, the financial performance of Madhusudan Sec. indicates a challenging year with substantial losses and declining asset values.

Who are the top shareholders of the Madhusudan Sec.?

The top shareholders of Madhusudan Securities are Primus Retail Private Limited at 10.82% and Foresight Holdings Private Limited at 8.78%, with individual investors holding 54.45%. There are no pledged promoter holdings, and the company has no mutual funds or foreign institutional investors as shareholders.

The top shareholders of Madhusudan Securities include Primus Retail Private Limited, which holds 10.82%, and Foresight Holdings Private Limited, the promoter with the highest holding at 8.78%. Additionally, individual investors collectively hold a significant portion of 54.45%. It's important to note that there are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors holding shares.

What is the technical trend for Madhusudan Sec.?

As of April 28, 2025, Madhusudan Sec. exhibits a mildly bearish trend, influenced by bearish daily moving averages and Bollinger Bands, while mixed signals from MACD and KST across different timeframes suggest a lack of strong upward momentum.

As of 28 April 2025, the technical trend for Madhusudan Sec. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The daily moving averages are bearish, and both the weekly and monthly Bollinger Bands indicate a bearish trend. While the weekly MACD and KST show a mildly bullish signal, the monthly MACD and KST are mildly bearish, suggesting a lack of strong upward momentum. The Dow Theory indicates a mildly bullish stance on the weekly timeframe but shows no trend on the monthly. Overall, the mixed signals across different timeframes contribute to a mildly bearish outlook.

Has Madhusudan Sec. declared dividend?

No Dividend History Available